Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee substitutes wide-ranging medical cannabis package, then pauses final action after contentious testimony
Summary
Lawmakers moved HB 203 to a fourth substitute that tightens licensing and creates a medical cannabis ombudsman and other regulatory changes, but after lengthy public debate the committee deferred final action and moved to the next agenda item; the bill was not voted out of committee on the day.
The Health and Human Services Committee considered HB 203 (medical cannabis amendments), approved a motion to substitute a new fourth substitute, and then—after extensive public testimony and debate—took no final floor vote on the bill and moved on to other business.
Sponsor remarks summarized the bill as a package intended to stabilize the medical cannabis market, increase oversight and transparency, and add limited new pharmacy licenses. Key elements described by the sponsor included:
- Creation of a medical cannabis ombudsman position to provide independent oversight and a neutral appeal option where the…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
